This Study Will Look At The Safety Of Sodium Benzoate, And At How Well It Works In Improving Symptoms Of Schizophrenia When Added To Current Medication
Posted Date: Jan 28, 2020
- Investigator: Caleb Adler
- Specialties:
- Type of Study: Drug
AN ADAPTIVE, PHASE IIB/III, MULTI-CENTER, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF NABEN® (SODIUM BENZOATE), A D-AMINO ACID OXIDASE INHIBITOR, AS AN ADD-ON TREATMENT FOR SCHIZOPHRENIA IN ADULTS
Criteria:
Men And Women 18-45 Years Old Who Have Been Diagnosed With Schizophrenia For At Least 2 Years
Keywords:
Schizophrenia, Adults
For More Information:
Karen Tugrul, Rn
513-558-6831
tugrulkc@ucmail.uc.edu